Clazakizumab: A Therapeutic Approach for Patients With Late Antibody-Mediated Rejection.

ABSTRACT:

SUBMITTER: Jordan SC 

PROVIDER: S-EPMC12640071 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature